“I truly doubt that there is another psychedelic drug, anywhere, that can match this one for speed, for intensity, for brevity, and sensitive to dose, at least one that is active orally”
“To be on a trip & then to be back pretty much in two hours & really baseline in another hour? Most unusual. If there will ever be an acceptance of drugs such as these, in a psychotherapeutic context, a short duration is of extreme value to both the patient & the therapist.”
6/9
Greenway DNA: “Methods & Systems for Providing a Personalized Treatment Regimen Using Cannabinoid or Psychedelic Compounds”
Providing “personalized psychedelic compound treatment regimen” to patient based on genotypes of single nucleotide polymorphisms from genetic testing
7/9
Small Pharma: “Deuterated N,N-Dimethyltryptmine Compounds”
“compositions and methods which enable a finely tuned single dose to maintain a patient in full dissociation from the external world, referred to herein as ‘DMT space,’ for a therapeutically optimised duration”
What happens when two companies’ patents both cover the same drug?
Reunion Neuroscience’s lead RE104 = isoprocin glutarate, a prodrug of 4-OH-DiPT
Reunion $REUN has a granted patent claiming it
Today, Mindset Pharma $MSET received a notice of allowance on claims to it too
1/7
Field Trip $FTRP (the original applicant) obtained its patent on RE104 (then FT-104) after first w/drawing it from issuance to ensure examiner reviewed Mindset’s apps
Mindset’s were filed first, but only published after Field Trip’s app was allowed
New patent granted—“Delivery System for Ayahuasca-Like Substances”
Claims DMT vapes, 5-MeO-DMT vapes, & 2C-B vapes
These claims can be immediately enforced
1/6
The patent claims:
“A device for the delivery of a substance comprising:
a chamber comprising at least one vaporizable formulation wherein the vaporizable formulation comprises the substance and wherein the substance comprises one or more of”
DMT, 5-MeO-DMT, or 2C-B
2/6
The application was first filed as a provisional in July 2020
Did DMT vape pens exist in the prior art before the priority date?
This @doubleblindmag article was first published on Feb. 5, 2020: